Fibrogenesis serum markers in patients with chronic hepatitis C treated with α-IFN

被引：31

作者：

Fabris, P ^{[1
]}

Marranconi, F ^{[1
]}

Bozzola, L ^{[1
]}

Biasin, MR ^{[1
]}

De Lazzari, F ^{[1
]}

Plebani, M ^{[1
]}

Benedetti, P ^{[1
]}

Tositti, G ^{[1
]}

Pellizzer, G ^{[1
]}

Stecca, C ^{[1
]}

de Lalla, F ^{[1
]}

机构：

[1] San Bortolo Hosp, Dept Infect Dis, I-36100 Vicenza, Italy

来源：

JOURNAL OF GASTROENTEROLOGY | 1999年 / 34卷 / 03期

关键词：

chronic hepatitis C; HCV; interferon therapy; liver fibrosis;

D O I：

10.1007/s005350050272

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

The correlation between therapeutic response and liver fibrogenesis was studied in serum and liver specimens taken from 31 patients treated with alpha-interferon (IFN) (14 sustained responders and 17 nonresponders) for chronic hepatitis C. Serum samples, collected before therapy, and at further G-month intervals over 2 pears, were tested for markers of liver neofibrogenesis. Serum N-terminal procollagen III peptide (PIIINP) displayed a significant and persistent decrease (P < 0.05) in sustained responders but not in non-responders; significantly lowered (P < 0.05) mean levels of C-terminal procollagen I peptide (PICP) were transiently observed in both patient groups, apparently as a result of IFN administration. Serum laminin (Lam) levels remained unchanged. One year after the cessation of treatment, liver biopsy re-testing showed an improvement in necro-inflammatory scores only in sustained responders, with the histological fibrosis scores remaining unaltered in both groups. IFN treatment seemed to exert an influence on serum levels of markers of hepatic connective tissue turnover even in patients that did not respond to therapy, while no effect was observed on preexistent liver fibrosis.

引用

页码：345 / 350

页数：6

共 33 条

[11] AN IMMUNOASSAY FOR SPECIFIC AMPLIFIED HCV SEQUENCES [J].

IMBERTI, L ;

CARIANI, E ;

BETTINARDI, A ;

ZONARO, A ;

ALBERTINI, A ;

PRIMI, D .

JOURNAL OF VIROLOGICAL METHODS, 1991, 34 (03) :233-243

[12] ABILITY OF PROLONGED INTERFERON TREATMENT TO SUPPRESS RELAPSE AFTER CESSATION OF THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C - A MULTICENTER RANDOMIZED CONTROLLED TRIAL [J].

KASAHARA, A ;

HAYASHI, N ;

HIRAMATSU, N ;

OSHITA, M ;

HAGIWARA, H ;

KATAYAMA, K ;

KATO, M ;

MASUZAWA, M ;

YOSHIHARA, H ;

KISHIDA, Y ;

SHIMIZU, Y ;

INOUE, A ;

FUSAMOTO, H ;

KAMADA, T .

HEPATOLOGY, 1995, 21 (02) :291-297

[13] Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C [J].

Kasahara, A ;

Hayashi, N ;

Mochizuki, K ;

Takayanagi, M ;

Yoshioka, K ;

Kakumu, S ;

Iijima, A ;

Urushihara, A ;

Kiyosawa, K ;

Okuda, M ;

Hino, K ;

Okita, K .

HEPATOLOGY, 1998, 27 (05) :1394-1402

[14] THE SIGNIFICANCE OF BLOOD-TRANSFUSION IN NON-A, NON-B CHRONIC LIVER-DISEASE IN JAPAN [J].

KIYOSAWA, K ;

AKAHANE, Y ;

NAGATA, A ;

KOIKE, Y ;

FURUTA, S .

VOX SANGUINIS, 1982, 43 (01) :45-52

[15] FORMULATION AND APPLICATION OF A NUMERICAL SCORING SYSTEM FOR ASSESSING HISTOLOGICAL ACTIVITY IN ASYMPTOMATIC CHRONIC ACTIVE HEPATITIS [J].

KNODELL, RG ;

ISHAK, KG ;

BLACK, WC ;

CHEN, TS ;

CRAIG, R ;

KAPLOWITZ, N ;

KIERNAN, TW ;

WOLLMAN, J .

HEPATOLOGY, 1981, 1 (05) :431-435

[16] INTERFERON-ALFA AND INTERFERON-GAMMA INHIBIT PROLIFERATION AND COLLAGEN-SYNTHESIS OF HUMAN ITO CELLS IN CULTURE [J].

MALLAT, A ;

PREAUX, AM ;

BLAZEJEWSKI, S ;

ROSENBAUM, J ;

DHUMEAUX, D ;

MAVIER, P .

HEPATOLOGY, 1995, 21 (04) :1003-1010

[17]

MANABE N, 1993, HEPATOLOGY, V18, P1344, DOI 10.1002/hep.1840180610

[18]

NAKANO Y, 1990, AM J GASTROENTEROL, V85, P24

[19] CELLULAR-DISTRIBUTION OF TRANSFORMING GROWTH FACTOR-BETA-1 AND PROCOLLAGEN TYPE-1, TYPE-III, TYPE-IV TRANSCRIPTS IN CARBON TETRACHLORIDE-INDUCED RAT-LIVER FIBROSIS [J].

NAKATSUKASA, H ;

NAGY, P ;

EVARTS, RP ;

HSIA, CC ;

MARSDEN, E ;

THORGEIRSSON, SS .

JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (06) :1833-1843

[20] RANDOMIZED TRIAL OF EFFECTS OF INTERFERON-ALPHA ON INCIDENCE OF HEPATOCELLULAR-CARCINOMA IN CHRONIC ACTIVE HEPATITIS-C WITH CIRRHOSIS [J].

NISHIGUCHI, S ;

KUROKI, T ;

NAKATANI, S ;

MORIMOTO, H ;

TAKEDA, T ;

NAKAJIMA, S ;

SHIOMI, S ;

SEKI, S ;

KOBAYASHI, K ;

OTANI, S .

LANCET, 1995, 346 (8982) :1051-1055

← 1 2 3 4 →